Option chain shows key data for PharmaCielo's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for PharmaCielo.

PharmaCielo (OTC:PCLOF) Stock, Option Chain

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

ibrahim-rifath-OApHds2yEGQ-unsplash(9)

Cannabis

Earnings

News

PCLOF

TSX:PCLO

TSXV:PCLO

Cannabis products company PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) announced on Monday financial and operational results for the three and nine months ended Sept. 30, 2024. The Toronto-based company said revenue for the third quarter totaled CA$1.3 million ($927,772), up from CA$352,000 in the prior year&#39;s period. For the nine months, total revenues reached CA$2.4 million, compared to CA$1.3 million in 2023. &#34;PharmaCielo achieved substantial revenue growth, successfully expanded into new international markets, and continued its focus on reducing costs to improve its operational efficiency,&#34; Marc Lustig, chairman and CEO of PharmaCielo, said. &#34;Our strategic position in multiple regions, coupled with an expanding product portfolio beyond CBD isolate, has enhanced our ability to serve diverse international markets and generate increased revenue.&#34;

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Screen Shot 2024-10-24 at 13.36.47

Latin America

Regulations

Exclusives

Interview

AVCNF

CLVR

FLGC

OWPC

TSX:AVCN

Colombia&#39;s cannabis decree allows dry flower sales, but ex-official claims it won&#39;t just protect small producers—most companies may qualify.

Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify

Europe Euro rain Cannabis (M.KOS and MVelishchuk on Shutterstock)

Education

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

TLRY

TSX:WEED

WEED

The Czech Republic could be missing out on hundreds of millions of euros annually as the governing coalition remains persistent in avoiding establishing a regulated marijuana market. That&#39;s according to the findings of a comprehensive study examining the possible costs and benefits of various cannabis reform models being proposed nationwide.

This European Country Could Lose $242M A Year If It Doesn&#39;t Regulate Its Marijuana Market, Study Finds

PharmaCielo Ltd

PharmaCielo

Comments

PharmaCielo

PharmaCielo (PCLOF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga